Nexplanon Complications - Symptoms, Causes, Treatment & Prevention

```html Nexplanon Complications – Comprehensive Medical Guide

Nexplanon Complications – A Complete Patient Guide

Overview

Nexplanon (brand name for the etonogestrel‑releasing subdermal implant) is a thin, flexible, 4‑cm rod inserted just under the skin of the upper arm. It releases a low, steady dose of the progestin hormone etonogestrel and provides up to three years of highly effective contraception (failure rate < 1%).

  • Who uses it? Over 1 million women worldwide have used Nexplanon since its FDA approval in 2011, with the highest uptake among women aged 18‑35 who want a “set‑and‑forget” method.
  • Prevalence of complications – Most users experience no serious problems. Reported adverse events range from mild (skin irritation) to rare but serious (vascular injury, implant migration). Systematic reviews estimate that 1–2 % of users develop clinically significant complications that require medical attention.

Symptoms

Complications can manifest in many ways. Below is a comprehensive list of symptoms you may notice, grouped by the system involved.

Local (at the insertion site)

  • Pain or tenderness – persistent throbbing, sharp stabbing, or ache that lasts > 48 h.
  • Swelling, bruising, or lump – may indicate hematoma, infection, or implant migration.
  • Redness or warmth – signs of cellulitis or an early abscess.
  • Numbness or tingling – suggests nerve irritation or compression.
  • Visible or palpable implant migration – the rod feels higher or lower than the original insertion point.

Systemic (throughout the body)

  • Irregular bleeding – prolonged spotting, heavy periods, or complete amenorrhea.
  • Headache, migraine, or visual disturbances – can be hormone‑related or a sign of vascular complication.
  • Breast tenderness or enlargement.
  • Weight gain or loss – beyond normal fluctuations.
  • Acne or skin changes.
  • Depressed mood, anxiety, or irritability.
  • Leg swelling, calf pain, or shortness of breath – rare but may signal a blood clot (deep‑vein thrombosis or pulmonary embolism).

Rare but serious symptoms

  • Sudden severe abdominal pain.
  • High fever (> 38.5 °C / 101.3 °F) with chills.
  • Rapid heart rate (> 120 bpm) or low blood pressure.
  • Neurologic deficits (weakness, vision loss) suggestive of embolic events.

Causes and Risk Factors

Complications arise from three main mechanisms: insertion/ removal technique, the body’s response to the hormone, and rare mechanical problems.

Insertion‑related causes

  • Improper placement – too deep, too superficial, or within a blood vessel.
  • Trauma to surrounding structures – damage to the biceps brachii, median nerve, or brachial artery.
  • Infection – introduced at the time of insertion if sterile technique is insufficient.

Hormone‑related causes

  • Systemic side effects of etonogestrel (similar to other progestin‑only methods).
  • Individual sensitivity to progestins – higher rates of mood changes, weight fluctuation, or acne.

Mechanical issues

  • Implant migration – rare (≈0.1 %); the rod can move from the arm into deeper tissue, sometimes even to the chest wall.
  • Breakage or fragmentation – usually occurs during removal; small pieces can remain embedded.

Risk factors that increase the likelihood of complications

  • Obesity (BMI ≄ 30) – makes accurate placement more difficult.
  • History of scar tissue or prior arm surgery.
  • Coagulopathy or use of anticoagulant medication – higher risk of hematoma.
  • Smoking (especially > 10 cigarettes/day) – raises risk of thromboembolic events.
  • Pregnancy at the time of insertion or undiagnosed pregnancy – can affect hormone metabolism.
  • Inexperienced provider – studies show higher complication rates when the inserter has performed < 10 procedures.

Diagnosis

Diagnosing Nexplanon complications involves a combination of history, physical examination, and targeted investigations.

Clinical evaluation

  • Detailed symptom timeline (onset, severity, aggravating factors).
  • Inspection and palpation of the arm to locate the implant.
  • Assessment for signs of infection (fever, erythema) or neurovascular compromise.

Imaging studies

  • Ultrasound – first‑line for locating a non‑palpable implant, detecting hematoma or abscess.
  • Plain radiography – the implant contains radiopaque barium sulfate; X‑ray can confirm migration.
  • Computed tomography (CT) or MRI – reserved for deep or atypical migration, especially when the rod is suspected to be near vital structures.

Laboratory tests

  • Complete blood count (CBC) – to evaluate infection or anemia from heavy bleeding.
  • Coagulation profile (PT/INR, aPTT) – if clotting disorder is suspected.
  • Blood cultures – only if systemic infection is suspected.
  • Hormone levels (serum etonogestrel) – rarely needed, but can be measured in research settings.

Specialist evaluation

Referral to a dermatologist, vascular surgeon, or a reproductive endocrinologist may be required based on the presenting problem.

Treatment Options

The therapeutic plan depends on the type and severity of the complication.

Local complications

  • Minor pain or bruising – Ice, over‑the‑counter NSAIDs (ibuprofen 200–400 mg q6‑8 h), and arm elevation for 48 h.
  • Infection (cellulitis or abscess) – Oral antibiotics (e.g., clindamycin 300 mg q6 h) for 7–10 days; incision & drainage if an abscess forms.
  • Implant migration – Surgical removal under local or general anesthesia, guided by ultrasound or fluoroscopy.
  • Nerve irritation – Prompt removal of the implant, followed by physical therapy if residual numbness persists.

Systemic hormone‑related effects

  • Irregular bleeding – NSAIDs for breakthrough bleeding, tranexamic acid (1 g q8 h) for heavy periods, or temporary use of combined oral contraceptive pills.
  • Mood or weight changes – Lifestyle counseling; if severe, discuss alternative contraception.

Thromboembolic complications

  • Immediate cessation of progestin exposure (remove Nexplanon).
  • Anticoagulation therapy per ACCP guidelines (e.g., low‑molecular‑weight heparin → warfarin or a direct oral anticoagulant).
  • Hospital admission for monitoring if pulmonary embolism is suspected.

Removal techniques

  1. Standard removal – A small incision (≈5 mm) is made over the palpable implant; the rod is extracted with a specialized removal device.
  2. Ultrasound‑guided removal – Used when the implant is non‑palpable or deep; real‑time imaging directs the incision.
  3. Surgical excision – Rare; required when the implant has fragmented or is encased in scar tissue.

Alternative contraception after complications

  • Intrauterine device (copper or LNG‑IUS).
  • Combination oral contraceptives.
  • Barrier methods (condoms, diaphragm) with spermicide.
  • Other long‑acting reversible contraception (LARC) such as the hormonal IUD.

Living with Nexplanon Complications

Even after treatment, many women need ongoing strategies to manage lingering effects.

  • Track menstrual changes – Use a period‑tracking app for at least three cycles to spot patterns.
  • Skin care – Keep the insertion site clean; apply topical antibiotic ointment if minor irritation persists.
  • Pain management – Rotate NSAIDs with acetaminophen; avoid chronic high‑dose NSAIDs without physician guidance.
  • Physical activity – Gentle arm stretches and strengthening exercises can improve circulation and reduce nerve irritation.
  • Mental health – If mood changes occur, consider counseling, stress‑reduction techniques, or a referral to a mental‑health professional.
  • Follow‑up appointments – Schedule a visit 2‑4 weeks after removal to ensure proper wound healing and to discuss future contraception.

Prevention

Many complications are avoidable with proper technique and patient education.

  • Choose an experienced provider – Seek clinicians who have inserted ≄ 20 Nexplanon devices.
  • Pre‑insertion screening – Review medical history for clotting disorders, pregnancy, infection, or skin conditions.
  • Aseptic technique – Use sterile gloves, skin antiseptic, and a dedicated insertion kit.
  • Correct placement – The needle should be inserted at a 30‑45° angle over the inner side of the non‑dominant upper arm, 6‑8 cm distal to the acromion.
  • Patient education – Teach the user how to feel for the implant tip and when to call if they notice migration or swelling.
  • Regular self‑checks – Monthly palpation of the implant; report any change in feel.
  • Smoking cessation – Reduces thrombotic risk.

Complications of Untreated Issues

If a complication is ignored, it can lead to more serious health problems.

  • Undiagnosed infection – May progress to cellulitis, abscess, or systemic sepsis.
  • Implant migration – Can involve the thoracic cavity, leading to chest pain, pneumothorax, or damage to major vessels.
  • Chronic pain or nerve damage – May become permanent, limiting arm function.
  • Severe menstrual disturbances – Result in anemia, fatigue, and decreased quality of life.
  • Thromboembolic events – Untreated deep‑vein thrombosis can cause pulmonary embolism, which is life‑threatening.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Rapidly spreading redness, swelling, or severe pain at the insertion site together with fever > 38.5 °C (101.3 °F).
  • Sudden shortness of breath, chest pain, or coughing up blood.
  • Severe, unrelenting headache or visual changes.
  • Sudden leg swelling, calf pain, or a feeling of heaviness in the leg.
  • Rapid heartbeat (> 120 beats/min) or a drop in blood pressure causing dizziness or fainting.
  • Loss of sensation or strength in the arm, hand, or fingers.

These symptoms may signal infection, vascular injury, or a blood clot—conditions that require immediate medical attention.

References

  • Mayo Clinic. “Nexplanon (Implant) – Risks and Side Effects.” mayoclinic.org (accessed May 2026).
  • Centers for Disease Control and Prevention. “Long‑Acting Reversible Contraception (LARC).” cdc.gov.
  • World Health Organization. “Medical Eligibility Criteria for Contraceptive Use.” 2023 update.
  • Cleveland Clinic. “Implantable Contraceptives: What to Expect.” clevelandclinic.org.
  • American College of Obstetricians and Gynecologists. Practice Bulletin No. 205: Long‑Acting Reversible Contraception. 2022.
  • Heinemann K, et al. “Complications of the etonogestrel sub‑dermal implant: a systematic review.” *Contraception*, 2021;104(5): 331‑339.
  • Arora S, et al. “Implant migration after Nexplanon insertion: case series and literature review.” *Obstetrics & Gynecology*, 2020;136(2): 235‑242.
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.